Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Metabolic Effects of Atazanavir/Ritonavir Versus Darunavir/Ritonavir in Combination With Tenofovir/Emtricitabine in naïve HIV-1 Infected Patients

This study has been completed.
Information provided by (Responsible Party):
Juan A. Arnaiz, Hospital Clinic of Barcelona Identifier:
First received: January 11, 2011
Last updated: December 15, 2014
Last verified: December 2014